Summary
Cyber- and motion sickness are debilitating for many people, limiting both travel opportunities, and the use of new technologies such as virtual and augmented reality. These forms of sickness are due to nauseogenic sensory mismatch (NSM). Cybersickness affects up to 50% of people use who AR and VR headsets. Motion sickness affects 30% of travellers in all forms of transport, with even more getting sick if they use AR or VR as a passenger. To mitigate the effects of NSM, the PhotoMod project will demonstrate the efficacy of a novel transcranial photobiomodulation (tPBM) technique using near-infrared light. This is delivered by LEDs on the scalp shining invisible light into the brain, focused on the human vestibular network (HVN) to create neural entrainment.
Our novel method extends work on the ERC ViAjeRo project which used transcranial alternating current stimulation to create entrainment in the HVN. We use this to synchronize the phase information of endogenous neural oscillations associated with NSM in the HVN to an external phase stimulus generated by tACS, which mirrors healthy phase information. We have found very significant benefits for NSM with this method. However, tACS has many drawbacks for commercial application. tPBM overcomes all of these as it is: more precise, safer, more comfortable and cheaper. In PhotoMod, we will develop new hardware and software to deliver tPBM in a commercial form, then test it as a mitigation for cybersickness at home and for motion sickness on the road. The final result will be a commercialisable wearable system that can mitigate the effects of cyber and motion sickness across a wide area of applications.
Our novel method extends work on the ERC ViAjeRo project which used transcranial alternating current stimulation to create entrainment in the HVN. We use this to synchronize the phase information of endogenous neural oscillations associated with NSM in the HVN to an external phase stimulus generated by tACS, which mirrors healthy phase information. We have found very significant benefits for NSM with this method. However, tACS has many drawbacks for commercial application. tPBM overcomes all of these as it is: more precise, safer, more comfortable and cheaper. In PhotoMod, we will develop new hardware and software to deliver tPBM in a commercial form, then test it as a mitigation for cybersickness at home and for motion sickness on the road. The final result will be a commercialisable wearable system that can mitigate the effects of cyber and motion sickness across a wide area of applications.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101188662 |
| Start date: | 01-01-2025 |
| End date: | 30-06-2026 |
| Total budget - Public funding: | - 150 000,00 Euro |
Cordis data
Original description
Cyber- and motion sickness are debilitating for many people, limiting both travel opportunities, and the use of new technologies such as virtual and augmented reality. These forms of sickness are due to nauseogenic sensory mismatch (NSM). Cybersickness affects up to 50% of people use who AR and VR headsets. Motion sickness affects 30% of travellers in all forms of transport, with even more getting sick if they use AR or VR as a passenger. To mitigate the effects of NSM, the PhotoMod project will demonstrate the efficacy of a novel transcranial photobiomodulation (tPBM) technique using near-infrared light. This is delivered by LEDs on the scalp shining invisible light into the brain, focused on the human vestibular network (HVN) to create neural entrainment.Our novel method extends work on the ERC ViAjeRo project which used transcranial alternating current stimulation to create entrainment in the HVN. We use this to synchronize the phase information of endogenous neural oscillations associated with NSM in the HVN to an external phase stimulus generated by tACS, which mirrors healthy phase information. We have found very significant benefits for NSM with this method. However, tACS has many drawbacks for commercial application. tPBM overcomes all of these as it is: more precise, safer, more comfortable and cheaper. In PhotoMod, we will develop new hardware and software to deliver tPBM in a commercial form, then test it as a mitigation for cybersickness at home and for motion sickness on the road. The final result will be a commercialisable wearable system that can mitigate the effects of cyber and motion sickness across a wide area of applications.
Status
SIGNEDCall topic
ERC-2024-POCUpdate Date
24-11-2024
Images
No images available.
Geographical location(s)
